RPID Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
8.1M
+0.6%
8.0M
-29.1%
11.3M
+43.9%
7.8M
+7.9%
7.3M
Cost of Revenue
6.8M
-10.3%
7.6M
-34.3%
11.6M
+62.6%
7.1M
+2.2%
7.0M
Gross Profit
1.2M
+226.7%
371.0K
+213.1%
-328000
-147.1%
696.0K
+153.1%
275.0K
Operating Expenses
13.5M
-4.8%
14.2M
+19.7%
11.9M
-1.5%
12.1M
-2.9%
12.4M
R&D
3.3M
-0.8%
3.4M
+4.3%
3.2M
-8.8%
3.5M
+9.3%
3.2M
SG&A
10.2M
-6.1%
10.9M
+25.4%
8.7M
+1.5%
8.5M
-7.1%
9.2M
Operating Income
-12322000
+11.0%
-13852000
-13.4%
-12211000
-7.4%
-11372000
+6.4%
-12148000
EBITDA
-11648000
+11.4%
-13146000
-15.1%
-11421000
-8.1%
-10568000
+6.8%
-11337000
Net Income
-12923000
+9.5%
-14275000
-14.2%
-12497000
-8.6%
-11505000
+3.0%
-11858000
EPS (Basic)
$-0.27
+12.9%
$-0.31
-10.7%
$-0.28
-7.7%
$-0.26
+3.7%
$-0.27
EPS (Diluted)
$-0.27
+12.9%
$-0.31
-10.7%
$-0.28
-7.7%
$-0.26
+3.7%
$-0.27
Shares (Diluted)
48.3M
+6.4%
45.4M
+0.7%
45.1M
+0.4%
45.0M
+0.7%
44.6M
Rapid Micro Biosystems (RPID) โ€” Financials